DOXAZOSIN

DOXAZOSIN was reported 36429 times

DOXAZOSIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 20 0.6667
1 SPIROMETRY ABNORMAL 148 0.2475
2 PULMONARY VASCULITIS 127 0.2361
3 VENA CAVA INJURY 21 0.2283
4 MITE ALLERGY 146 0.2229
5 TOTAL LUNG CAPACITY ABNORMAL 85 0.2185
6 CAPILLARITIS 57 0.2065
7 MYCOTIC ALLERGY 146 0.1708
8 DUST ALLERGY 149 0.1519
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 93 0.1269
10 RENAL CYST HAEMORRHAGE 26 0.1150
11 RENIN INCREASED 30 0.1099
12 CONJUNCTIVITIS ALLERGIC 157 0.1059
13 NEURITIS 130 0.0841
14 CARDIOSPASM 45 0.0806
15 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 21 0.0772
16 VASCULAR COMPRESSION 22 0.0696
17 IMMUNISATION 29 0.0668
18 CAROTID ARTERIOSCLEROSIS 63 0.0610
19 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 18 0.0594
20 PALMOPLANTAR KERATODERMA 43 0.0593
21 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 117 0.0573
22 NORMOCHROMIC NORMOCYTIC ANAEMIA 160 0.0532
23 PHAEOCHROMOCYTOMA 35 0.0531
24 LOWER URINARY TRACT SYMPTOMS 17 0.0470
25 HYPERPARATHYROIDISM SECONDARY 115 0.0459
26 DELAYED GRAFT FUNCTION 32 0.0450
27 RENAL ARTERY STENOSIS 62 0.0450
28 RESPIRATORY SYMPTOM 126 0.0443
29 RECTAL PROLAPSE 51 0.0422
30 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 44 0.0414
31 NEPHROGENIC ANAEMIA 177 0.0382
32 GRAVITATIONAL OEDEMA 21 0.0302
33 FORCED EXPIRATORY VOLUME DECREASED 85 0.0300
34 SCROTAL OEDEMA 21 0.0295
35 AORTIC DILATATION 31 0.0279
36 INTERVERTEBRAL DISC SPACE NARROWING 21 0.0261
37 ARTERIOSCLEROSIS 240 0.0255
38 EROSIVE DUODENITIS 20 0.0250
39 ARTERIOSCLEROSIS CORONARY ARTERY 161 0.0243
40 PULMONARY ALVEOLAR HAEMORRHAGE 132 0.0235
41 NEUROLOGICAL SYMPTOM 132 0.0231
42 COMPLICATIONS OF TRANSPLANTED KIDNEY 51 0.0225
43 ATRIAL TACHYCARDIA 46 0.0219
44 LEFT VENTRICULAR HYPERTROPHY 92 0.0215
45 BENIGN PROSTATIC HYPERPLASIA 101 0.0195
46 PRURITUS GENITAL 44 0.0187
47 HYPERTENSIVE CRISIS 206 0.0185
48 ATRIOVENTRICULAR BLOCK FIRST DEGREE 78 0.0180
49 HYPERPARATHYROIDISM 36 0.0175
50 END STAGE RENAL DISEASE 308 0.0169
51 OBSTRUCTIVE AIRWAYS DISORDER 186 0.0167
52 PRODUCT MONITORING ERROR 24 0.0166
53 DILATATION ATRIAL 19 0.0163
54 VASCULITIS 182 0.0156
55 REBOUND ACID HYPERSECRETION 46 0.0152
56 AORTIC ARTERIOSCLEROSIS 39 0.0151
57 FULL BLOOD COUNT ABNORMAL 160 0.0151
58 CAROTID ARTERY OCCLUSION 55 0.0151
59 ORTHOSTATIC HYPOTENSION 261 0.0150
60 ACTINIC KERATOSIS 38 0.0146
61 NEPHROGENIC SYSTEMIC FIBROSIS 41 0.0136
62 TENSION HEADACHE 58 0.0135
63 ORTHOPNOEA 42 0.0132
64 BLOOD PRESSURE INADEQUATELY CONTROLLED 79 0.0131
65 HYPERKALAEMIA 430 0.0122
66 NODULE 159 0.0122
67 URINE FLOW DECREASED 29 0.0121
68 ESSENTIAL HYPERTENSION 22 0.0120
69 HYPERTENSIVE HEART DISEASE 22 0.0118
70 TROPONIN I INCREASED 19 0.0114
71 BRADYARRHYTHMIA 18 0.0109
72 HEPATOSPLENOMEGALY 28 0.0109
73 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 36 0.0109
74 SKIN INDURATION 22 0.0106
75 DIABETIC NEPHROPATHY 23 0.0104
76 SLEEP TERROR 44 0.0104
77 KIDNEY FIBROSIS 18 0.0104
78 COLONIC POLYP 17 0.0103
79 RENAL CYST 80 0.0101
80 DIVERTICULUM INTESTINAL 44 0.0101
81 TACHYARRHYTHMIA 25 0.0100
82 KIDNEY TRANSPLANT REJECTION 47 0.0098
83 HAEMORRHAGIC ANAEMIA 43 0.0098
84 AZOTAEMIA 39 0.0098
85 MEAN CELL VOLUME INCREASED 25 0.0097
86 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 86 0.0097
87 AORTIC VALVE INCOMPETENCE 40 0.0094
88 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 159 0.0094
89 HYPERURICAEMIA 38 0.0092
90 HYPOMAGNESAEMIA 128 0.0092
91 PRESYNCOPE 221 0.0091
92 CHRONIC KIDNEY DISEASE 671 0.0088
93 VENTRICULAR HYPERTROPHY 22 0.0088
94 PSYCHOTIC SYMPTOM 18 0.0087
95 CONCOMITANT DISEASE PROGRESSION 17 0.0087
96 PULMONARY FIBROSIS 166 0.0086
97 COMA SCALE ABNORMAL 25 0.0086
98 ANURIA 74 0.0086
99 DILATATION VENTRICULAR 18 0.0086
100 JAUNDICE CHOLESTATIC 30 0.0085
101 ISCHAEMIC CARDIOMYOPATHY 26 0.0085
102 PRIAPISM 29 0.0084
103 HYPONATRAEMIA 471 0.0084
104 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 34 0.0083
105 AORTIC STENOSIS 29 0.0083
106 NOCTURIA 100 0.0082
107 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 20 0.0081
108 SOPOR 107 0.0081
109 OLIGURIA 50 0.0080
110 UPPER GASTROINTESTINAL HAEMORRHAGE 131 0.0078
111 BUNDLE BRANCH BLOCK LEFT 33 0.0078
112 METHAEMOGLOBINAEMIA 18 0.0078
113 DIASTOLIC DYSFUNCTION 24 0.0078
114 GLOMERULONEPHRITIS 19 0.0078
115 ACUTE KIDNEY INJURY 1178 0.0077
116 POLYURIA 63 0.0077
117 CLONUS 21 0.0077
118 BLOOD LACTIC ACID INCREASED 40 0.0076
119 CARDIOMEGALY 93 0.0076
120 METABOLIC ACIDOSIS 241 0.0075
121 ATRIOVENTRICULAR BLOCK 58 0.0075
122 GLOMERULAR FILTRATION RATE DECREASED 91 0.0074
123 MELAENA 162 0.0074
124 SINUS BRADYCARDIA 71 0.0073
125 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 37 0.0073
126 SPINAL STENOSIS 30 0.0073
127 SYNCOPE 716 0.0071
128 SKIN HYPERTROPHY 20 0.0071
129 SUBARACHNOID HAEMORRHAGE 72 0.0071
130 RENAL FAILURE CHRONIC 54 0.0070
131 CORONARY ARTERY STENOSIS 35 0.0070
132 HYPOXIA 245 0.0070
133 TUBULOINTERSTITIAL NEPHRITIS 130 0.0069
134 URINE OUTPUT INCREASED 18 0.0069
135 GASTRITIS EROSIVE 32 0.0069
136 BRADYCARDIA 363 0.0068
137 HAEMOPTYSIS 190 0.0068
138 ACIDOSIS 52 0.0068
139 SQUAMOUS CELL CARCINOMA OF SKIN 41 0.0068
140 DIZZINESS POSTURAL 65 0.0067
141 EXCORIATION 17 0.0067
142 DYSLIPIDAEMIA 34 0.0067
143 TRICUSPID VALVE INCOMPETENCE 53 0.0067
144 PRODUCTIVE COUGH 316 0.0066
145 PROSTATIC DISORDER 36 0.0065
146 PULSELESS ELECTRICAL ACTIVITY 27 0.0065
147 RADICULOPATHY 17 0.0064
148 GOUT 115 0.0064
149 APLASIA PURE RED CELL 22 0.0064
150 BLOOD POTASSIUM ABNORMAL 17 0.0064
151 PROSTATOMEGALY 25 0.0064
152 MITRAL VALVE INCOMPETENCE 72 0.0064
153 LARGE INTESTINE POLYP 44 0.0063
154 ECCHYMOSIS 43 0.0063
155 PROSTATITIS 19 0.0062
156 URINARY INCONTINENCE 184 0.0062
157 SPINAL OSTEOARTHRITIS 54 0.0061
158 RENAL IMPAIRMENT 513 0.0061
159 DUODENAL ULCER 43 0.0061
160 HYPERREFLEXIA 21 0.0060
161 ATRIOVENTRICULAR BLOCK COMPLETE 40 0.0060
162 PERIORBITAL OEDEMA 31 0.0060
163 FACIAL PAIN 53 0.0059
164 HYPOKALAEMIA 273 0.0059
165 RENAL TUBULAR NECROSIS 58 0.0059
166 SUBDURAL HAEMATOMA 84 0.0059
167 DYSPNOEA AT REST 17 0.0059
168 RENAL FAILURE 777 0.0058
169 HYPOTHYROIDISM 186 0.0058
170 CAROTID ARTERY STENOSIS 20 0.0057
171 BLOOD POTASSIUM INCREASED 92 0.0057
172 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 58 0.0056
173 BLOOD CREATINE INCREASED 25 0.0056
174 CARDIAC FAILURE CHRONIC 24 0.0056
175 DRUG INTERACTION 893 0.0056
176 LACTIC ACIDOSIS 182 0.0056
177 LIP SWELLING 187 0.0056
178 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
179 MYOCARDIAL ISCHAEMIA 63 0.0055
180 CIRCULATORY COLLAPSE 94 0.0055
181 GRANULOMA 19 0.0055
182 HYPOGLYCAEMIA 265 0.0055
183 RENAL FAILURE ACUTE 230 0.0054
184 PROSTATE CANCER METASTATIC 18 0.0054
185 BLOOD UREA INCREASED 90 0.0054
186 HYPOCALCAEMIA 101 0.0053
187 IRON DEFICIENCY 24 0.0053
188 ERECTILE DYSFUNCTION 137 0.0053
189 DIABETIC RETINOPATHY 18 0.0053
190 BLOOD CREATININE INCREASED 346 0.0053
191 RENAL INJURY 157 0.0053
192 CONGESTIVE CARDIOMYOPATHY 22 0.0053
193 NEPHROPATHY 49 0.0052
194 MYOPATHY 45 0.0052
195 CARDIAC MURMUR 45 0.0052
196 ATRIAL FLUTTER 41 0.0051
197 BASAL CELL CARCINOMA 80 0.0051
198 VENTRICULAR TACHYCARDIA 84 0.0051
199 SPRUE-LIKE ENTEROPATHY 25 0.0051
200 HYPOTENSION 1014 0.0050
201 EXERCISE TOLERANCE DECREASED 29 0.0050
202 ABDOMINAL TENDERNESS 25 0.0050
203 HYPERNATRAEMIA 25 0.0050
204 ANGIOEDEMA 221 0.0050
205 PROTEINURIA 94 0.0049
206 WHEEZING 293 0.0049
207 DIVERTICULUM 35 0.0049
208 THROMBOTIC MICROANGIOPATHY 48 0.0049
209 HYPERVOLAEMIA 24 0.0049
210 URINARY RETENTION 162 0.0049
211 ATRIAL FIBRILLATION 470 0.0048
212 GINGIVITIS 26 0.0048
213 VENTRICULAR EXTRASYSTOLES 50 0.0048
214 BUNDLE BRANCH BLOCK RIGHT 22 0.0048
215 ISCHAEMIA 22 0.0048
216 HYPOVOLAEMIA 28 0.0048
217 INTERNATIONAL NORMALISED RATIO INCREASED 135 0.0047
218 CORONARY ARTERY DISEASE 143 0.0047
219 OEDEMA PERIPHERAL 570 0.0047
220 OESOPHAGEAL DISORDER 18 0.0047
221 HAEMATURIA 160 0.0047
222 HYPERCHOLESTEROLAEMIA 45 0.0047
223 IRON DEFICIENCY ANAEMIA 43 0.0047
224 PERIPHERAL ISCHAEMIA 19 0.0046
225 INFLAMMATORY MARKER INCREASED 23 0.0046
226 ANGINA UNSTABLE 30 0.0046
227 HYPERLIPIDAEMIA 55 0.0046
228 SUPRAVENTRICULAR TACHYCARDIA 44 0.0046
229 CORONARY ARTERY OCCLUSION 63 0.0046
230 BLOOD URIC ACID INCREASED 26 0.0045
231 ISCHAEMIC STROKE 80 0.0045
232 TRANSIENT ISCHAEMIC ATTACK 151 0.0045
233 CEREBRAL ISCHAEMIA 23 0.0045
234 GINGIVAL BLEEDING 61 0.0045
235 PERIPHERAL VASCULAR DISORDER 23 0.0045
236 UROSEPSIS 41 0.0044
237 POLLAKIURIA 185 0.0044
238 BLOOD PRESSURE FLUCTUATION 105 0.0044
239 PEMPHIGOID 33 0.0044
240 PULMONARY HYPERTENSION 91 0.0044
241 LUMBAR VERTEBRAL FRACTURE 20 0.0044
242 HAEMORRHAGIC STROKE 34 0.0043
243 ANGINA PECTORIS 124 0.0043
244 POLYDIPSIA 17 0.0043
245 SWELLING OF EYELID 27 0.0043
246 HYPERTENSION 909 0.0043
247 DYSURIA 157 0.0043
248 RECTAL HAEMORRHAGE 182 0.0042
249 OESOPHAGITIS 46 0.0042
250 MICTURITION URGENCY 48 0.0042
251 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
252 DIABETES MELLITUS INADEQUATE CONTROL 74 0.0042
253 GASTRIC ULCER HAEMORRHAGE 23 0.0041
254 DERMATITIS BULLOUS 30 0.0041
255 PROSTATIC SPECIFIC ANTIGEN INCREASED 57 0.0041
256 ACUTE MYOCARDIAL INFARCTION 122 0.0041
257 POLYP 27 0.0041
258 GASTRIC ULCER 78 0.0041
259 HIATUS HERNIA 53 0.0041
260 CEREBRAL HAEMORRHAGE 146 0.0041
261 BLOOD PRESSURE ABNORMAL 81 0.0041
262 DECREASED INTEREST 24 0.0041
263 BREATH SOUNDS ABNORMAL 20 0.0041
264 CARDIAC FAILURE ACUTE 27 0.0040
265 LYMPHOEDEMA 28 0.0040
266 PANCREATITIS ACUTE 91 0.0040
267 SKIN TIGHTNESS 19 0.0040
268 BLOOD COUNT ABNORMAL 61 0.0040
269 LIP OEDEMA 17 0.0040
270 ANOSMIA 58 0.0040
271 MUSCLE TWITCHING 92 0.0040
272 ACUTE CORONARY SYNDROME 33 0.0040
273 SLEEP APNOEA SYNDROME 76 0.0040
274 HAEMATOMA 103 0.0040
275 SOMNAMBULISM 26 0.0040
276 HAEMODIALYSIS 33 0.0039
277 CARDIAC FAILURE CONGESTIVE 315 0.0039
278 CARDIAC FLUTTER 25 0.0039
279 PURPURA 34 0.0038
280 ELECTROCARDIOGRAM ABNORMAL 30 0.0038
281 HEPATITIS CHOLESTATIC 23 0.0038
282 ABNORMAL LOSS OF WEIGHT 26 0.0038
283 SALIVARY HYPERSECRETION 38 0.0038
284 FLUID INTAKE REDUCED 19 0.0038
285 HAEMORRHOIDS 74 0.0038
286 GASTROINTESTINAL HAEMORRHAGE 317 0.0038
287 NEUTROPENIC SEPSIS 27 0.0038
288 TENSION 23 0.0038
289 DIPLOPIA 98 0.0038
290 RHABDOMYOLYSIS 157 0.0038
291 VITAMIN D DECREASED 32 0.0037
292 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
293 RHINITIS 30 0.0037
294 CONFUSIONAL STATE 601 0.0037
295 HEART RATE IRREGULAR 84 0.0037
296 BLOOD PRESSURE INCREASED 568 0.0037
297 SWOLLEN TONGUE 116 0.0037
298 SHOCK 85 0.0037
299 LUNG DISORDER 181 0.0037
300 LETHARGY 212 0.0037
301 CARDIAC VALVE DISEASE 21 0.0037
302 DIALYSIS 52 0.0037
303 URINE OUTPUT DECREASED 32 0.0037
304 NEPHROTIC SYNDROME 25 0.0036
305 DYSPNOEA EXERTIONAL 137 0.0036
306 HEAD INJURY 115 0.0036
307 SPINAL COLUMN STENOSIS 17 0.0036
308 HEPATIC STEATOSIS 67 0.0036
309 EXTRASYSTOLES 25 0.0036
310 PULSE ABSENT 17 0.0036
311 UNRESPONSIVE TO STIMULI 92 0.0036
312 CONCOMITANT DISEASE AGGRAVATED 22 0.0036
313 MUSCLE ATROPHY 45 0.0035
314 AORTIC ANEURYSM 27 0.0035
315 MOUTH HAEMORRHAGE 26 0.0035
316 HAEMORRHAGE INTRACRANIAL 53 0.0035
317 BLOOD PRESSURE SYSTOLIC INCREASED 69 0.0035
318 BRADYPHRENIA 23 0.0035
319 VENTRICULAR FIBRILLATION 39 0.0035
320 FAECES DISCOLOURED 76 0.0035
321 LOSS OF CONSCIOUSNESS 449 0.0035
322 INCONTINENCE 37 0.0035
323 EJECTION FRACTION DECREASED 54 0.0035
324 NEPHROPATHY TOXIC 39 0.0035
325 DIABETIC NEUROPATHY 17 0.0034
326 ANHEDONIA 90 0.0034
327 GROIN PAIN 30 0.0034
328 ATELECTASIS 33 0.0034
329 ANAEMIA 651 0.0034
330 HYPERGLYCAEMIA 124 0.0034
331 ANGIOPATHY 19 0.0034
332 BRADYKINESIA 20 0.0034
333 AMNESIA 220 0.0034
334 MIDDLE INSOMNIA 63 0.0034
335 FLUID OVERLOAD 49 0.0034
336 CORONARY ARTERIAL STENT INSERTION 17 0.0033
337 HAEMATEMESIS 85 0.0033
338 CARDIAC FAILURE 269 0.0033
339 PULMONARY OEDEMA 150 0.0033
340 BLOOD SODIUM DECREASED 63 0.0033
341 LOWER RESPIRATORY TRACT INFECTION 152 0.0033
342 BLOOD URINE PRESENT 63 0.0033
343 EOSINOPHILIA 58 0.0033
344 SEROTONIN SYNDROME 63 0.0033
345 THROMBOSIS 263 0.0033
346 MEDICATION ERROR 181 0.0033
347 CELLULITIS 164 0.0033
348 SPLENOMEGALY 38 0.0032
349 PALPITATIONS 379 0.0032
350 EPISTAXIS 242 0.0032
351 MYOSITIS 29 0.0032
352 MUSCULOSKELETAL CHEST PAIN 50 0.0032
353 ASTHMA 365 0.0032
354 HEART RATE ABNORMAL 18 0.0032
355 GASTROENTERITIS 47 0.0032
356 PERICARDITIS 54 0.0032
357 SHOCK HAEMORRHAGIC 26 0.0032
358 GASTRITIS 84 0.0032
359 ELECTROLYTE IMBALANCE 37 0.0032
360 HICCUPS 26 0.0032
361 ARRHYTHMIA 150 0.0032
362 HAEMOGLOBIN DECREASED 325 0.0032
363 HALLUCINATION 238 0.0032
364 TINNITUS 145 0.0032
365 CARDIOGENIC SHOCK 45 0.0031
366 MUSCULAR WEAKNESS 354 0.0031
367 HEART RATE DECREASED 109 0.0031
368 PULMONARY EMBOLISM 294 0.0031
369 BLOOD PRESSURE DECREASED 205 0.0031
370 HYPERKERATOSIS 17 0.0031
371 OEDEMA 167 0.0031
372 BLOOD TESTOSTERONE DECREASED 21 0.0031
373 JOINT SWELLING 368 0.0030
374 NEOPLASM 35 0.0030
375 GLUCOSE TOLERANCE IMPAIRED 18 0.0030
376 LARGE INTESTINE PERFORATION 21 0.0030
377 THIRST 54 0.0030
378 BLADDER DISORDER 30 0.0030
379 RENAL PAIN 32 0.0030
380 HAEMODYNAMIC INSTABILITY 23 0.0030
381 HEMIPARESIS 51 0.0030
382 COAGULOPATHY 50 0.0030
383 CHOLECYSTITIS ACUTE 17 0.0030
384 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 144 0.0030
385 SWELLING FACE 195 0.0030
386 LOCAL SWELLING 52 0.0030
387 MYASTHENIA GRAVIS 24 0.0030
388 MULTI-ORGAN FAILURE 51 0.0029
389 HYDRONEPHROSIS 22 0.0029
390 PLEURAL EFFUSION 178 0.0029
391 EYE INFECTION 33 0.0029
392 DYSARTHRIA 110 0.0029
393 C-REACTIVE PROTEIN INCREASED 106 0.0029
394 SPINAL COMPRESSION FRACTURE 24 0.0029
395 PHARYNGITIS 36 0.0029
396 JOINT EFFUSION 20 0.0029
397 FEELING OF BODY TEMPERATURE CHANGE 17 0.0029
398 NIGHTMARE 100 0.0029
399 LIVER FUNCTION TEST ABNORMAL 84 0.0029
400 FAECES SOFT 21 0.0029
401 PULMONARY MASS 43 0.0029
402 DEHYDRATION 384 0.0029
403 VITAMIN D DEFICIENCY 28 0.0029
404 BLOOD CREATINE PHOSPHOKINASE INCREASED 82 0.0028
405 MENTAL STATUS CHANGES 79 0.0028
406 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 202 0.0028
407 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0028
408 HYPOKINESIA 41 0.0028
409 DELIRIUM 98 0.0028
410 VERTIGO 171 0.0028
411 RESTLESS LEGS SYNDROME 51 0.0028
412 TACHYCARDIA 249 0.0028
413 ARTERIAL OCCLUSIVE DISEASE 22 0.0028
414 INGUINAL HERNIA 17 0.0028
415 TENDERNESS 29 0.0028
416 DRUG LEVEL INCREASED 46 0.0028
417 PERIPHERAL SWELLING 427 0.0028
418 TOXIC EPIDERMAL NECROLYSIS 42 0.0028
419 COGNITIVE DISORDER 129 0.0028
420 LARYNGEAL OEDEMA 17 0.0028
421 CHOLELITHIASIS 90 0.0027
422 ASPERGILLUS INFECTION 18 0.0027
423 DIZZINESS 1364 0.0027
424 FLUID RETENTION 139 0.0027
425 STENT PLACEMENT 22 0.0027
426 RED BLOOD CELL COUNT DECREASED 78 0.0027
427 DYSPNOEA 1531 0.0027
428 KIDNEY INFECTION 53 0.0027
429 DISORIENTATION 107 0.0027
430 FACIAL PARALYSIS 23 0.0027
431 PERICARDIAL EFFUSION 62 0.0027
432 MYALGIA 451 0.0026
433 ACUTE RESPIRATORY FAILURE 51 0.0026
434 CHEST PAIN 491 0.0026
435 WOUND INFECTION 29 0.0026
436 BODY TEMPERATURE INCREASED 54 0.0026
437 ELECTROCARDIOGRAM QT PROLONGED 95 0.0026
438 RENAL DISORDER 123 0.0026
439 FEAR 71 0.0026
440 DRY MOUTH 214 0.0026
441 TROPONIN INCREASED 20 0.0026
442 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 137 0.0026
443 DERMATITIS ALLERGIC 33 0.0026
444 BODY HEIGHT DECREASED 28 0.0026
445 HEPATITIS ACUTE 17 0.0026
446 COLD SWEAT 46 0.0026
447 SENSORY LOSS 21 0.0026
448 HALLUCINATION, VISUAL 55 0.0026
449 CARDIAC ARREST 214 0.0026
450 PRURITUS GENERALISED 56 0.0026
451 EMPHYSEMA 26 0.0026
452 DECUBITUS ULCER 21 0.0026
453 HYPOTHERMIA 26 0.0026
454 ASTHENIA 965 0.0026
455 SKIN ULCER 66 0.0026
456 APHASIA 77 0.0025
457 DIABETIC KETOACIDOSIS 61 0.0025
458 GLYCOSYLATED HAEMOGLOBIN INCREASED 64 0.0025
459 DIVERTICULITIS 70 0.0025
460 SMALL INTESTINAL OBSTRUCTION 31 0.0025
461 EYE PRURITUS 84 0.0025
462 PNEUMONITIS 68 0.0025
463 PETECHIAE 26 0.0025
464 RESPIRATORY RATE INCREASED 22 0.0025
465 MYOCARDIAL INFARCTION 432 0.0025
466 DROOLING 17 0.0025
467 LACERATION 23 0.0024
468 SKIN HYPERPIGMENTATION 21 0.0024
469 HEPATOMEGALY 24 0.0024
470 NEUTROPHIL COUNT INCREASED 25 0.0024
471 DEPRESSED MOOD 129 0.0024
472 LEUKOCYTOSIS 44 0.0024
473 GENERALISED OEDEMA 30 0.0024
474 TORSADE DE POINTES 19 0.0024
475 BALANCE DISORDER 209 0.0024
476 JAUNDICE 65 0.0024
477 BLOOD POTASSIUM DECREASED 72 0.0024
478 SINUS TACHYCARDIA 34 0.0024
479 ADRENAL INSUFFICIENCY 29 0.0024
480 DYSPEPSIA 235 0.0024
481 SEXUAL DYSFUNCTION 28 0.0024
482 RETINAL HAEMORRHAGE 17 0.0024
483 OBESITY 38 0.0024
484 BLOOD GLUCOSE ABNORMAL 44 0.0024
485 INTERNAL HAEMORRHAGE 27 0.0024
486 CHEST DISCOMFORT 241 0.0024
487 PHARYNGEAL SWELLING 23 0.0023
488 HYPOPHAGIA 60 0.0023
489 POLYNEUROPATHY 28 0.0023
490 ROTATOR CUFF SYNDROME 30 0.0023
491 FALL 772 0.0023
492 DELUSION 36 0.0023
493 BLOOD CALCIUM DECREASED 26 0.0023
494 PYELONEPHRITIS 20 0.0023
495 BLINDNESS TRANSIENT 17 0.0023
496 BLINDNESS 93 0.0023
497 RESPIRATORY FAILURE 166 0.0023
498 INTERVERTEBRAL DISC DEGENERATION 21 0.0023
499 DIABETES MELLITUS 173 0.0023
500 LUNG INFILTRATION 20 0.0023
501 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
502 GINGIVAL PAIN 18 0.0023
503 TENDONITIS 35 0.0023
504 GASTRIC HAEMORRHAGE 26 0.0023
505 PANCYTOPENIA 126 0.0023
506 GASTROOESOPHAGEAL REFLUX DISEASE 181 0.0022
507 URINARY TRACT INFECTION 383 0.0022
508 FLANK PAIN 21 0.0022
509 PAIN OF SKIN 60 0.0022
510 HAEMATOCRIT DECREASED 44 0.0022
511 NECK PAIN 124 0.0022
512 HEART RATE INCREASED 218 0.0022
513 LIVER INJURY 54 0.0022
514 MUSCLE SPASTICITY 27 0.0022
515 FACE OEDEMA 37 0.0022
516 THERAPY NON-RESPONDER 98 0.0022
517 ECONOMIC PROBLEM 33 0.0022
518 ALTERED STATE OF CONSCIOUSNESS 47 0.0022
519 DRUG-INDUCED LIVER INJURY 68 0.0022
520 DRY THROAT 22 0.0022
521 MOTOR DYSFUNCTION 22 0.0022
522 RETCHING 46 0.0022
523 SKIN LESION 59 0.0021
524 HALLUCINATION, AUDITORY 34 0.0021
525 DISTURBANCE IN ATTENTION 115 0.0021
526 HOSPICE CARE 21 0.0021
527 HYPERBILIRUBINAEMIA 22 0.0021
528 SINUS DISORDER 42 0.0021
529 CONSTIPATION 460 0.0021
530 EAR PAIN 41 0.0021
531 MUSCLE SPASMS 387 0.0021
532 SPUTUM DISCOLOURED 20 0.0021
533 HYPERCALCAEMIA 26 0.0021
534 BLOOD GLUCOSE FLUCTUATION 23 0.0021
535 VISION BLURRED 288 0.0021
536 CARDIOMYOPATHY 31 0.0021
537 TREMOR 348 0.0021
538 WHITE BLOOD CELL COUNT INCREASED 80 0.0021
539 FEELING COLD 58 0.0021
540 FLATULENCE 118 0.0021
541 PAIN IN EXTREMITY 613 0.0021
542 VISUAL ACUITY REDUCED 69 0.0021
543 GLAUCOMA 40 0.0021
544 ABNORMAL FAECES 17 0.0021
545 TASTE DISORDER 42 0.0021
546 ANXIETY 589 0.0021
547 TREATMENT NONCOMPLIANCE 113 0.0021
548 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
549 CEREBROVASCULAR ACCIDENT 349 0.0021
550 MALNUTRITION 23 0.0021
551 BLISTER 115 0.0020
552 CEREBRAL INFARCTION 50 0.0020
553 DIARRHOEA 1308 0.0020
554 PALLOR 55 0.0020
555 SQUAMOUS CELL CARCINOMA 19 0.0020
556 DEEP VEIN THROMBOSIS 131 0.0020
557 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
558 SLEEP DISORDER 142 0.0020
559 ABDOMINAL DISTENSION 210 0.0020
560 HAEMOLYTIC ANAEMIA 18 0.0020
561 PNEUMONIA ASPIRATION 50 0.0020
562 LOSS OF LIBIDO 18 0.0020
563 JOINT DISLOCATION 21 0.0020
564 CYTOMEGALOVIRUS INFECTION 33 0.0020
565 SUDDEN DEATH 21 0.0020
566 CHOLESTASIS 38 0.0020
567 CONTUSION 190 0.0020
568 ASCITES 58 0.0020
569 AGEUSIA 49 0.0020
570 PNEUMONIA 635 0.0020
571 CONDITION AGGRAVATED 596 0.0020
572 MOUTH ULCERATION 41 0.0019
573 BACK PAIN 452 0.0019
574 COUGH 545 0.0019
575 ANOREXIA 25 0.0019
576 BURNING SENSATION 136 0.0019
577 JOINT RANGE OF MOTION DECREASED 26 0.0019
578 VISUAL IMPAIRMENT 240 0.0019
579 OSTEOARTHRITIS 82 0.0019
580 WOUND 54 0.0019
581 CARPAL TUNNEL SYNDROME 27 0.0019
582 RESPIRATORY ARREST 53 0.0019
583 ENCEPHALOPATHY 47 0.0019
584 HYPERHIDROSIS 246 0.0019
585 JOINT STIFFNESS 50 0.0019
586 RIB FRACTURE 39 0.0019
587 SCHIZOPHRENIA 23 0.0019
588 RHINORRHOEA 122 0.0019
589 PHARMACEUTICAL PRODUCT COMPLAINT 49 0.0019
590 CYSTITIS 60 0.0019
591 NEUROTOXICITY 33 0.0019
592 DYSPHONIA 110 0.0019
593 RASH PAPULAR 42 0.0019
594 MUSCULOSKELETAL PAIN 98 0.0019
595 TENDON RUPTURE 23 0.0019
596 SLUGGISHNESS 19 0.0019
597 ABDOMINAL PAIN 433 0.0019
598 DEMENTIA 52 0.0019
599 PNEUMONIA BACTERIAL 17 0.0019
600 CATARACT 110 0.0018
601 OSTEOPENIA 28 0.0018
602 ABDOMINAL DISCOMFORT 309 0.0018
603 TACHYPNOEA 25 0.0018
604 SECRETION DISCHARGE 23 0.0018
605 CANDIDA INFECTION 31 0.0018
606 DRUG DISPENSING ERROR 28 0.0018
607 VOMITING 861 0.0018
608 PERSONALITY CHANGE 17 0.0018
609 SEPSIS 204 0.0018
610 ASPIRATION 20 0.0018
611 TOOTHACHE 33 0.0018
612 ORAL CANDIDIASIS 24 0.0018
613 TOXICITY TO VARIOUS AGENTS 307 0.0018
614 PULMONARY CONGESTION 24 0.0018
615 PHARYNGEAL OEDEMA 28 0.0018
616 GASTROINTESTINAL PAIN 20 0.0018
617 MALAISE 797 0.0018
618 SOMNOLENCE 365 0.0018
619 DECREASED APPETITE 421 0.0018
620 ABNORMAL DREAMS 50 0.0018
621 NEPHROLITHIASIS 83 0.0018
622 SKIN EXFOLIATION 152 0.0018
623 MUSCULOSKELETAL DISCOMFORT 31 0.0018
624 INTRAOCULAR PRESSURE INCREASED 23 0.0018
625 DEAFNESS 47 0.0018
626 INTERSTITIAL LUNG DISEASE 87 0.0018
627 SPINAL FRACTURE 36 0.0018
628 HEPATOTOXICITY 40 0.0018
629 HAEMATOCHEZIA 99 0.0018
630 COORDINATION ABNORMAL 25 0.0018
631 ORAL PAIN 40 0.0018
632 APATHY 26 0.0018
633 BREAST PAIN 19 0.0018
634 ABNORMAL WEIGHT GAIN 22 0.0018
635 RESTLESSNESS 65 0.0018
636 PARAESTHESIA 279 0.0018
637 BLOOD ALKALINE PHOSPHATASE INCREASED 44 0.0018
638 RASH PRURITIC 96 0.0018
639 HAIR COLOUR CHANGES 22 0.0018
640 MOOD ALTERED 48 0.0018
641 MACULAR DEGENERATION 21 0.0018
642 ARTHRALGIA 729 0.0018
643 BRONCHOSPASM 25 0.0018
644 BLOOD GLUCOSE INCREASED 329 0.0017
645 PULMONARY THROMBOSIS 19 0.0017
646 BRAIN OEDEMA 22 0.0017
647 DYSPHAGIA 165 0.0017
648 ANAPHYLACTIC REACTION 96 0.0017
649 ABDOMINAL PAIN UPPER 356 0.0017
650 FATIGUE 1346 0.0017
651 MUSCLE TIGHTNESS 28 0.0017
652 GAIT DISTURBANCE 330 0.0017
653 EYE HAEMORRHAGE 23 0.0017
654 DEPRESSED LEVEL OF CONSCIOUSNESS 68 0.0017
655 QUALITY OF LIFE DECREASED 23 0.0017
656 BONE PAIN 100 0.0017
657 SPINAL PAIN 20 0.0017
658 HERNIA 33 0.0017
659 ERUCTATION 33 0.0017
660 SINUS CONGESTION 23 0.0017
661 DYSKINESIA 69 0.0017
662 GENERAL PHYSICAL HEALTH DETERIORATION 196 0.0017
663 EYE SWELLING 63 0.0017
664 INJURY 119 0.0017
665 ILEUS 21 0.0017
666 NEUROLEPTIC MALIGNANT SYNDROME 20 0.0017
667 NIGHT SWEATS 54 0.0017
668 PERIPHERAL COLDNESS 23 0.0017
669 DRUG RESISTANCE 43 0.0017
670 SKIN CANCER 36 0.0017
671 WEIGHT DECREASED 466 0.0017
672 BACTERIAL INFECTION 31 0.0017
673 RASH GENERALISED 43 0.0017
674 BRAIN FOG 26 0.0017
675 DRUG ABUSE 138 0.0017
676 LACRIMATION INCREASED 50 0.0017
677 LOCALISED INFECTION 40 0.0017
678 PLATELET COUNT DECREASED 176 0.0016
679 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
680 DYSSTASIA 48 0.0016
681 OXYGEN SATURATION DECREASED 92 0.0016
682 HAEMORRHAGE 171 0.0016
683 EYELID OEDEMA 19 0.0016
684 POST PROCEDURAL HAEMORRHAGE 19 0.0016
685 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
686 BLINDNESS UNILATERAL 23 0.0016
687 PAIN IN JAW 46 0.0016
688 MEMORY IMPAIRMENT 223 0.0016
689 HEADACHE 1014 0.0016
690 HIP FRACTURE 52 0.0016
691 POST PROCEDURAL COMPLICATION 31 0.0016
692 PANCREATITIS 85 0.0016
693 ATAXIA 19 0.0016
694 BEDRIDDEN 21 0.0016
695 INSOMNIA 425 0.0016
696 PARAESTHESIA ORAL 23 0.0016
697 PERITONITIS 33 0.0016
698 SWELLING 149 0.0016
699 THROMBOCYTOPENIA 178 0.0016
700 ARTHRITIS 125 0.0016
701 LIVER FUNCTION TEST INCREASED 34 0.0016
702 FEMUR FRACTURE 49 0.0016
703 SCAB 18 0.0016
704 STAPHYLOCOCCAL INFECTION 52 0.0016
705 APHONIA 22 0.0016
706 OSTEONECROSIS OF JAW 39 0.0016
707 STEVENS-JOHNSON SYNDROME 35 0.0016
708 ULCER 25 0.0016
709 MALIGNANT MELANOMA 21 0.0016
710 HYPOAESTHESIA 234 0.0016
711 SKIN LACERATION 17 0.0016
712 CARDIAC DISORDER 146 0.0016
713 MULTIPLE ORGAN DYSFUNCTION SYNDROME 44 0.0016
714 AGITATION 114 0.0016
715 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 36 0.0015
716 ABDOMINAL PAIN LOWER 39 0.0015
717 PARALYSIS 22 0.0015
718 UPPER RESPIRATORY TRACT INFECTION 71 0.0015
719 DYSGEUSIA 114 0.0015
720 COLITIS 58 0.0015
721 PYREXIA 528 0.0015
722 HEAD DISCOMFORT 27 0.0015
723 SNEEZING 34 0.0015
724 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
725 PRODUCT PRESCRIBING ERROR 36 0.0015
726 DRUG PRESCRIBING ERROR 29 0.0015
727 NAUSEA 1192 0.0015
728 ABASIA 37 0.0015
729 CARDIOVASCULAR DISORDER 38 0.0015
730 IMPAIRED HEALING 49 0.0015
731 OSTEOMYELITIS 27 0.0015
732 PSYCHOTIC DISORDER 44 0.0015
733 SPEECH DISORDER 78 0.0015
734 TRANSAMINASES INCREASED 33 0.0015
735 LUNG INFECTION 23 0.0015
736 THROAT TIGHTNESS 40 0.0015
737 LYMPHOCYTE COUNT DECREASED 26 0.0015
738 FEELING ABNORMAL 352 0.0015
739 FEELING HOT 90 0.0015
740 HYPERSOMNIA 42 0.0015
741 SEIZURE 169 0.0015
742 CHROMATURIA 33 0.0015
743 INTESTINAL OBSTRUCTION 55 0.0015
744 EYE PAIN 82 0.0015
745 PNEUMOTHORAX 23 0.0014
746 THINKING ABNORMAL 27 0.0014
747 NEUTROPHIL COUNT DECREASED 59 0.0014
748 GASTROENTERITIS VIRAL 26 0.0014
749 COVID-19 PNEUMONIA 17 0.0014
750 LEUKOPENIA 72 0.0014
751 NEURALGIA 35 0.0014
752 FULL BLOOD COUNT DECREASED 29 0.0014
753 MOBILITY DECREASED 103 0.0014
754 EYE DISORDER 47 0.0014
755 DEVICE RELATED INFECTION 22 0.0014
756 TYPE 2 DIABETES MELLITUS 48 0.0014
757 MYOCLONUS 17 0.0014
758 ANKLE FRACTURE 22 0.0014
759 HAIR TEXTURE ABNORMAL 19 0.0014
760 BRONCHITIS 105 0.0014
761 SKIN DISCOLOURATION 65 0.0014
762 PRURITUS 542 0.0014
763 ROAD TRAFFIC ACCIDENT 59 0.0014
764 DEPRESSION 315 0.0014
765 CHOKING 27 0.0014
766 INTENTIONAL PRODUCT MISUSE 121 0.0014
767 HYPERTHYROIDISM 20 0.0014
768 ABSCESS 22 0.0014
769 FREQUENT BOWEL MOVEMENTS 37 0.0014
770 LIMB INJURY 37 0.0014
771 WEIGHT INCREASED 303 0.0014
772 VIRAL INFECTION 45 0.0014
773 RASH MACULO-PAPULAR 30 0.0013
774 GALLBLADDER DISORDER 24 0.0013
775 EPILEPSY 41 0.0013
776 RESPIRATORY DISTRESS 37 0.0013
777 OSTEOPOROSIS 55 0.0013
778 INTENTIONAL SELF-INJURY 27 0.0013
779 DRUG INTOLERANCE 129 0.0013
780 GASTROINTESTINAL DISORDER 119 0.0013
781 IMPAIRED GASTRIC EMPTYING 18 0.0013
782 MENTAL IMPAIRMENT 32 0.0013
783 COVID-19 230 0.0013
784 RESPIRATORY DISORDER 39 0.0013
785 POOR QUALITY SLEEP 28 0.0013
786 INFLAMMATION 67 0.0013
787 DRUG EFFECT INCOMPLETE 47 0.0013
788 RASH 564 0.0013
789 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 92 0.0013
790 LIMB DISCOMFORT 40 0.0013
791 EXTRAPYRAMIDAL DISORDER 32 0.0013
792 HERPES ZOSTER 74 0.0013
793 OROPHARYNGEAL PAIN 119 0.0013
794 NEUROPATHY PERIPHERAL 122 0.0013
795 THERAPY PARTIAL RESPONDER 20 0.0013
796 ANAPHYLACTIC SHOCK 33 0.0013
797 IMMUNODEFICIENCY 19 0.0013
798 CHILLS 149 0.0013
799 DRY EYE 63 0.0013
800 RESPIRATORY TRACT CONGESTION 20 0.0013
801 GAIT INABILITY 42 0.0013
802 RASH ERYTHEMATOUS 60 0.0013
803 PRESCRIBED UNDERDOSE 25 0.0013
804 DRUG TOXICITY 17 0.0012
805 THERAPY CESSATION 64 0.0012
806 CYTOKINE RELEASE SYNDROME 25 0.0012
807 ERYTHEMA 255 0.0012
808 INTENTIONAL OVERDOSE 79 0.0012
809 BACK DISORDER 20 0.0012
810 BLOOD GLUCOSE DECREASED 59 0.0012
811 ARTHROPATHY 68 0.0012
812 SEDATION 32 0.0012
813 SUICIDE ATTEMPT 74 0.0012
814 METASTASES TO BONE 20 0.0012
815 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
816 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
817 CYANOSIS 19 0.0012
818 COLON CANCER 18 0.0012
819 METASTASES TO LIVER 21 0.0012
820 SCIATICA 19 0.0012
821 PAIN 732 0.0012
822 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
823 LABORATORY TEST ABNORMAL 35 0.0012
824 SENSORY DISTURBANCE 19 0.0012
825 BLOOD CHOLESTEROL INCREASED 55 0.0012
826 COMA 56 0.0012
827 THYROID DISORDER 18 0.0012
828 MUSCULOSKELETAL STIFFNESS 102 0.0012
829 NASAL CONGESTION 68 0.0012
830 BONE DISORDER 21 0.0012
831 UNEVALUABLE EVENT 87 0.0011
832 SEPTIC SHOCK 50 0.0011
833 HYPOAESTHESIA ORAL 17 0.0011
834 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
835 JOINT INJURY 24 0.0011
836 INFLUENZA 125 0.0011
837 IRRITABLE BOWEL SYNDROME 24 0.0011
838 PROSTATE CANCER 90 0.0011
839 RASH MACULAR 39 0.0011
840 PRODUCT SUBSTITUTION ISSUE 64 0.0011
841 FOOT FRACTURE 21 0.0011
842 ALANINE AMINOTRANSFERASE INCREASED 68 0.0011
843 WRONG TECHNIQUE IN DRUG USAGE PROCESS 40 0.0011
844 HEPATIC ENZYME INCREASED 75 0.0011
845 DISEASE PROGRESSION 130 0.0011
846 MOOD SWINGS 35 0.0011
847 SINUSITIS 112 0.0011
848 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
849 HYPOACUSIS 47 0.0011
850 PRODUCT ADMINISTRATION ERROR 22 0.0011
851 INTENTIONAL PRODUCT USE ISSUE 95 0.0011
852 DISCOMFORT 66 0.0011
853 GASTRIC DISORDER 37 0.0011
854 DRUG EFFECT DECREASED 58 0.0011
855 OVERDOSE 232 0.0011
856 STOMATITIS 65 0.0011
857 MUCOSAL INFLAMMATION 28 0.0011
858 MOVEMENT DISORDER 34 0.0011
859 UPPER LIMB FRACTURE 21 0.0011
860 FLUSHING 107 0.0011
861 SCAR 18 0.0011
862 HYPERSENSITIVITY 195 0.0010
863 INFECTION 152 0.0010
864 MIGRAINE 100 0.0010
865 HEPATIC FUNCTION ABNORMAL 39 0.0010
866 EMOTIONAL DISTRESS 126 0.0010
867 ACCIDENTAL OVERDOSE 38 0.0010
868 BLOOD BILIRUBIN INCREASED 28 0.0010
869 ANGER 35 0.0010
870 INFLUENZA LIKE ILLNESS 85 0.0010
871 CARDIO-RESPIRATORY ARREST 43 0.0010
872 URTICARIA 171 0.0010
873 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
874 PANIC ATTACK 37 0.0010
875 SURGERY 59 0.0010
876 MALIGNANT NEOPLASM PROGRESSION 103 0.0010
877 DERMATITIS 21 0.0010
878 COMPLETED SUICIDE 83 0.0010
879 INCREASED APPETITE 19 0.0010
880 NEUTROPENIA 135 0.0010
881 TARDIVE DYSKINESIA 28 0.0010
882 DRUG INEFFECTIVE 1306 0.0010
883 LOWER LIMB FRACTURE 19 0.0010
884 LYMPHADENOPATHY 35 0.0010
885 DISEASE RECURRENCE 47 0.0010
886 NASOPHARYNGITIS 181 0.0010
887 CONVULSION 56 0.0010
888 HEPATITIS 25 0.0010
889 PLASMA CELL MYELOMA 38 0.0010
890 HOT FLUSH 73 0.0010
891 AGRANULOCYTOSIS 18 0.0010
892 DISABILITY 19 0.0010
893 DRUG ERUPTION 17 0.0010
894 HEPATIC CIRRHOSIS 18 0.0010
895 FEBRILE NEUTROPENIA 63 0.0009
896 OFF LABEL USE 831 0.0009
897 INTENTIONAL DOSE OMISSION 27 0.0009
898 DRUG ADMINISTRATION ERROR 29 0.0009
899 GLOSSODYNIA 21 0.0009
900 ALOPECIA 184 0.0009
901 BONE MARROW FAILURE 19 0.0009
902 HOSPITALISATION 143 0.0009
903 PRESCRIBED OVERDOSE 18 0.0009
904 DRY SKIN 124 0.0009
905 DYSTONIA 18 0.0009
906 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
907 LIVER DISORDER 41 0.0009
908 RESPIRATORY TRACT INFECTION 24 0.0009
909 NERVOUSNESS 48 0.0009
910 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
911 PHOTOPHOBIA 17 0.0009
912 AGGRESSION 45 0.0009
913 HEPATIC FAILURE 27 0.0009
914 FEELING JITTERY 17 0.0009
915 THERAPEUTIC RESPONSE UNEXPECTED 40 0.0009
916 PRODUCT DOSE OMISSION 57 0.0009
917 SKIN DISORDER 29 0.0009
918 THROAT IRRITATION 39 0.0009
919 THERAPY INTERRUPTED 62 0.0009
920 EATING DISORDER 18 0.0008
921 THERAPEUTIC RESPONSE DECREASED 51 0.0008
922 GYNAECOMASTIA 26 0.0008
923 FUNGAL INFECTION 28 0.0008
924 EYE IRRITATION 48 0.0008
925 NERVOUS SYSTEM DISORDER 26 0.0008
926 PANCREATIC CARCINOMA 24 0.0008
927 BONE DENSITY DECREASED 26 0.0008
928 PRODUCT USE IN UNAPPROVED INDICATION 205 0.0008
929 INCORRECT DOSE ADMINISTERED 187 0.0008
930 DEATH 703 0.0008
931 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
932 FIBROMYALGIA 19 0.0008
933 PRODUCT USE ISSUE 145 0.0008
934 ADVERSE DRUG REACTION 69 0.0008
935 DRUG DOSE OMISSION 126 0.0008
936 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
937 PRODUCT QUALITY ISSUE 103 0.0008
938 SUICIDAL IDEATION 69 0.0008
939 EXPIRED PRODUCT ADMINISTERED 25 0.0008
940 IRRITABILITY 44 0.0007
941 ECZEMA 38 0.0007
942 ILL-DEFINED DISORDER 44 0.0007
943 NEOPLASM PROGRESSION 25 0.0007
944 EAR INFECTION 19 0.0007
945 MENTAL DISORDER 31 0.0007
946 PSORIASIS 93 0.0007
947 INFUSION RELATED REACTION 47 0.0007
948 ABNORMAL BEHAVIOUR 28 0.0007
949 RHEUMATOID ARTHRITIS 80 0.0007
950 OCULAR HYPERAEMIA 33 0.0007
951 MYELOSUPPRESSION 24 0.0007
952 EMOTIONAL DISORDER 20 0.0006
953 INCORRECT DRUG ADMINISTRATION DURATION 18 0.0006
954 UNDERDOSE 46 0.0006
955 ADVERSE EVENT 58 0.0006
956 COLITIS ULCERATIVE 28 0.0006
957 PSORIATIC ARTHROPATHY 25 0.0006
958 CRYING 22 0.0006
959 NEOPLASM MALIGNANT 40 0.0006
960 WITHDRAWAL SYNDROME 25 0.0006
961 MULTIPLE SCLEROSIS RELAPSE 40 0.0006
962 INJECTION SITE HAEMORRHAGE 46 0.0006
963 MULTIPLE SCLEROSIS 27 0.0006
964 OSTEONECROSIS 18 0.0005
965 THERAPEUTIC RESPONSE SHORTENED 18 0.0005
966 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
967 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 96 0.0005
968 EXTRA DOSE ADMINISTERED 20 0.0005
969 SKIN IRRITATION 22 0.0005
970 DEVICE ISSUE 41 0.0005
971 PRODUCT DOSE OMISSION ISSUE 132 0.0004
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90 0.0004
973 BLADDER CANCER 25 0.0004
974 RENAL CANCER 20 0.0004
975 ILLNESS 43 0.0004
976 DERMATITIS ATOPIC 22 0.0004
977 LUNG NEOPLASM MALIGNANT 17 0.0004
978 DRUG WITHDRAWAL SYNDROME 36 0.0004
979 INJECTION SITE PAIN 123 0.0004
980 INJECTION SITE BRUISING 31 0.0004
981 SKIN BURNING SENSATION 27 0.0004
982 NO ADVERSE EVENT 68 0.0004
983 TREATMENT FAILURE 31 0.0004
984 INJECTION SITE ERYTHEMA 43 0.0003
985 ACNE 26 0.0003
986 DEVICE MALFUNCTION 23 0.0003
987 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
988 EXPOSURE DURING PREGNANCY 19 0.0003
989 INJECTION SITE SWELLING 22 0.0003
990 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
991 INJECTION SITE REACTION 18 0.0003
992 BREAST CANCER 21 0.0002
993 DRUG DEPENDENCE 22 0.0001